PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33376625-0	2021	ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.	Cisplatin	75-84	casein kinase 2 alpha 2	Homo sapiens	92-100	
33376625-7	2021	Finally, ALKBH5 inhibited the progression and sensitized bladder cancer cells to cisplatin through a casein kinase 2 (CK2)alpha-mediated glycolysis pathway in an m6A-dependent manner.	Cisplatin	81-90	casein kinase 2 alpha 2	Homo sapiens	118-127	
20371694-9	2010	CK2 subunits modulated gene expression and the malignant phenotype involved in cell cycle and migration, whereas CK2alpha is critical to promote proliferation, antiapoptosis, and cisplatin resistance in vitro.	Cisplatin	179-188	casein kinase 2 alpha 2	Homo sapiens	113-121	
24831064-0	2014	RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2alpha) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.	Cisplatin	139-148	casein kinase 2 alpha 2	Homo sapiens	61-82	
24831064-0	2014	RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2alpha) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.	Cisplatin	139-148	casein kinase 2 alpha 2	Homo sapiens	84-92	
24831064-7	2014	Moreover, suppression of CK2alpha was found to enhance the apoptosis induced by cisplatin in laryngeal carcinoma cells, probably through inhibition of permeability glycoprotein (P-glycoprotein) and multidrug-resistance protein (MRP1).	Cisplatin	80-89	casein kinase 2 alpha 2	Homo sapiens	25-33